Measurable Residual IDH2 before Allogeneic Transplant for Acute Myeloid Leukemia

被引：1

作者：

Gui, Gege ^{[1
,2
]}

Dillon, Laura W. ^{[1
]}

Ravindra, Niveditha ^{[1
]}

Hegde, Pranay S. ^{[1
]}

Andrew, Georgia ^{[1
]}

Mukherjee, Devdeep ^{[1
]}

Wong, Zoe ^{[1
]}

Auletta, Jeffery J. ^{[3
,4
]}

El Chaer, Firas ^{[5
]}

Chen, Evan C. ^{[6
]}

Chen, Bin ^{[7
]}

Corner, Adam ^{[8
]}

Devine, Steven M. ^{[9
]}

Iyer, Sunil G. ^{[10
]}

Jimenez, Antonio M. Jimenez ^{[11
]}

De Lima, Marcos ^{[12
]}

Litzow, Mark R. ^{[13
]}

Kebriaei, Partow ^{[14
]}

Saber, Wael ^{[4
,15
]}

Spellman, Stephen R. ^{[4
,16
]}

Zeger, Scott L. ^{[2
]}

Page, Kristin M. ^{[4
,15
]}

Hourigan, Christopher S. ^{[17
]}

机构：

[1] Natl Heart Lung & Blood Inst, Hematol Branch, Lab Myeloid Malignancies, Bethesda, MD USA

[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA

[3] Nationwide Childrens Hosp, Hematol Oncol Bone Marrow Transplant & Infect Dis, Columbus, OH USA

[4] Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA

[5] Univ Virginia, Div Hematol & Oncol, Dept Med, Comprehens Canc Ctr,Med Ctr, Charlottesville, VA USA

[6] Dana Farber Canc Inst, Boston, MA USA

[7] Massachusetts Gen Hosp, Boston, MA USA

[8] Biorad Labs, Pleasanton, CA USA

[9] Natl Marrow Donor Program Be Match, CIBMTR Ctr Int Blood & Marrow Transplant Res, Minneapolis, MN USA

[10] Columbia Univ, Div Hematol & Oncol, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY USA

[11] Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA

[12] Ohio State Univ, Div Hematol, Wexner Med Ctr, Columbus, OH USA

[13] Mayo Clin, Div Hematol, Rochester, MN USA

[14] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX USA

[15] Med Coll Wisconsin, Milwaukee, WI USA

[16] Natl Marrow Donor Program, Minneapolis, MN USA

[17] NIH, Myeloid Malignancies Program, Bethesda, MD USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-186822

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?
Petrova, Lucie
Vrbacky, Filip
Lanska, Miriam
Zavrelova, Alzbeta
Zak, Pavel
Hrochova, Katerina
CLINICAL BIOCHEMISTRY, 2018, 61 : 34 - 39
[22] The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia
Abou Dalle, Iman
DiNardo, Courtney D.
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (07) : 163 - 173
[23] Enasidenib for Patients With Relapsed Acute Myeloid Leukemia and the IDH2 Mutation
DiNardo, Courtney
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (04) : 247 - 249
[24] Impact of IDH1 and IDH2 mutational subgroups in acute myeloid leukemia patients after allogeneic hematopoietic cell transplantation
Kunadt, D.
Stasik, S.
Metzeler, K.
Roellig, C.
Kramer, M.
Greif, P.
Spiekermann, K.
Rothenberg-Thurley, M.
Krug, U.
Braess, J.
Kraemer, A.
Hochhaus, A.
Bruemmendorf, T.
Jost, E.
Steffen, B.
Bug, G.
Einsele, H.
Burchert, A.
Neubauer, A.
Goerlich, D.
Sauerland, C.
Schaefer-Eckart, K.
Schliemann, C.
Stelljes, M.
Krause, S.
Haenel, M.
Hanoun, M.
Kaufmann, M.
Woermann, B.
Sockel, K.
Ruhnke, L.
Egger-Heidrich, K.
Herold, T.
Mueller-Tidow, C.
Platzbecker, U.
Berdel, W.
Serve, H.
Baldus, C.
Ehninger, G.
Hiddemann, W.
Schetelig, J.
Thiede, C.
Bornhaeuser, M.
Middeke, J. M.
Stoelzel, F.
BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 17 - 17
[25] Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm
Issa, Ghayas C.
DiNardo, Courtney D.
BLOOD CANCER JOURNAL, 2021, 11 (06)
[26] The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
Nassereddine, Samah
Lap, Coen J.
Haroun, Faysal
Tabbara, Imad
ANNALS OF HEMATOLOGY, 2017, 96 (12) : 1983 - 1991
[27] The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia
Samah Nassereddine
Coen J. Lap
Faysal Haroun
Imad Tabbara
Annals of Hematology, 2017, 96 : 1983 - 1991
[28] Acute Myeloid Leukemia With IDH1 or IDH2 Mutation Frequency and Clinicopathologic Features
Patel, Keyur P.
Ravandi, Farhad
Ma, Deqin
Paladugu, Abhaya
Barkoh, Bedia A.
Medeiros, L. Jeffrey
Luthra, Rajyalakshmi
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (01) : 35 - 45
[29] Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm
Ghayas C. Issa
Courtney D. DiNardo
Blood Cancer Journal, 11
[30] Importance of monitoring clonal dynamics of IDH2 mutations in Acute Myeloid Leukemia
Song, Jinming
David, Sallman
Padron, Eric
Sharma, Rohit
Hussaini, Mohammad
MODERN PATHOLOGY, 2019, 32

← 1 2 3 4 5 →